Clinical guidelines

Citations 1-10 of 32 total displayed.

Most recent content (Sep 2009): Safe Handling of Parenteral Cytotoxics: Recommendations for Ontario Esther Green, Mary Johnston, Maureen Trudeau, Lisa Schwartz, Susan Poirier, Gail Macartney, Deborah Milliken JOP Sep 2009: 245-249. Abstract Full Text PDF CiteTrack Past content (since Nov 2005): Poor Documentation Prevents Adequate Assessment of Quality Metrics in Colorectal Cancer Amy P. Abernethy, James E. Herndon, II, Jane L. Wheeler, Krista Rowe, Jennifer Marcello, Meenal Patwardhan JOP Jul 2009: 167-174. Abstract Full Text PDF CiteTrack American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction JOP Jul 2009: 196-199. Full Text PDF Data Supplements Guidelines and Associated Tools CiteTrack Participating in Medicare's E-Prescribing Incentive Program JOP Jul 2009: 200-201. Full Text PDF CiteTrack Use of 5--Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary JOP May 2009: 127-129. Full Text PDF Data Supplements Guidelines and Associated Tools CiteTrack Medicare Advantage: Reforms Needed to Ensure Access to Clinical Trials JOP May 2009: 144-145. Full Text PDF CiteTrack Telephone Triage in Today's Oncology Practice Elaine Towle JOP Mar 2009: 61. Full Text PDF CiteTrack ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab—Clinical Implications in Colorectal Cancer Roscoe F. Morton, Elizabeth H. Hammond JOP Mar 2009: 71-72. Full Text PDF Data Supplement CiteTrack Provisional Clinical Opinion Daniel G. Haller, John V. Cox JOP Mar 2009: 73. Full Text PDF Data Supplement CiteTrack Legislative Outlook: Opportunities and Challenges Joseph S. Bailes JOP Mar 2009: 91. Full Text PDF CiteTrack [Next page] Pages: 1 2 3 4